The Ministry of Health and the Ministry of Family have launched a joint discussion on the issue of gender dysphoria in minors, with special reference to the use of triptorelin, a drug that blocks puberty. This initiative is being led by Ministers Orazio Schillaci and Eugenia Roccella, who have brought together a team of technicians and experts to develop new guidelines based on scientific literature and experiences from other countries.

The joint statement of the two ministries announced this initiative and highlighted the work that has been done so far to solve gender dysphoria and the use of blockers. The statement mentions the involvement of scientific societies, the National Bioethics Committee and research conducted in various regions regarding the clinical and financial aspects of prescribing triptorelin.

The press release also states a request for a report from AIFA on the therapeutic indications for the drug. This collaborative effort aims to review the use of triptorelin in cases of gender dysphoria in minors and establish clear guidelines for its use in the future. The composition of the expert panel will be finalized in the coming days to further advance this important discussion.

By Samantha Johnson

As a dedicated content writer at, I immerse myself in the art of storytelling through words. With a keen eye for detail and a passion for crafting engaging narratives, I strive to captivate our audience with each piece I create. Whether I'm covering breaking news, delving into feature articles, or exploring thought-provoking editorials, my goal remains constant: to inform, entertain, and inspire through the power of writing. Join me on this journalistic journey as we navigate through the ever-evolving media landscape together.

Leave a Reply